Hacker News Reader

Comment by andsoitis | Hacker News Reader

Drug companies have a portfolio of compounds they research. Most don’t pay off, so R&D costs make their way into the pricing of those superstar and other drugs that do work. Also, timelines are pretty long.

View on HN

Well, R&D costs are able to make their way into the pricing due to the artificial supply restriction.

If supply was not artificially restricted (through patents), then competitors would be able to manufacture the drug, supply would expand, the price would collapse, and the original inventor would not be able to recover their R&D costs.

Drug companies spend more on marketing than R&D

So?

So pharmaceutical companies spend far less on marketing outside the US, partly because every other country besides New Zealand makes those incessant drug ads illegal, and partly because governments negotiate prices and keep profit margins down. If the argument is that R&D costs are what make drugs expensive, then we could easily eliminate an even greater expense by just copying what other developed nations do.

Don’t you think drug companies would be doing that (not advertise) if it would increase their profit?

Of course advertising increases their profit. It does that by increasing their revenue even more than the cost of the advertising.

For the rest of us, that giant increase in revenue is an increase in our healthcare costs.

Ah so sounds like your logic is: ban advertising -> less costs -> less revenue & lower patient costs -> same profit.

I think I can spot a flaw in that logic.

That last step contradicts my previous comment.

Reply on news.ycombinator.com